Now I have sufficient material from the textbooks. Let me compile a comprehensive long-question answer on IUGR from the paediatric perspective.
Intrauterine Growth Restriction (IUGR) - Long Question (Paediatrics)
Definition
Intrauterine Growth Restriction (IUGR) refers to a condition in which the fetus fails to achieve its genetically predetermined growth potential. It is most commonly defined as a birth weight below the 10th percentile for gestational age (some definitions use the 3rd or 5th percentile, or >2 SD below the mean). It should be distinguished from "Small for Gestational Age (SGA)," which is purely a statistical birth weight descriptor; IUGR specifically implies a pathological failure of growth as detected by serial ultrasonography.
- Medical Physiology, p. 1678; Robbins & Kumar Basic Pathology, p. 136
Classification
IUGR is classified into three types based on the timing and nature of the causative insult:
1. Symmetrical IUGR (20-30% of cases)
- All parameters affected uniformly: weight, length, head circumference all <10th percentile
- Results from a long-standing insult in early gestation (4-20 weeks) during the hyperplastic phase (when cell numbers increase)
- Fewer total cells in the fetus ("decreased cell number")
- Causes: Chromosomal disorders (trisomies), congenital infections (TORCH: Rubella, CMV, Toxoplasmosis), congenital malformations, maternal alcohol/drug/tobacco use, severe maternal malnutrition
- ~25% of severely affected early-onset cases have aneuploidy
2. Asymmetrical IUGR (70-80% of cases)
- Weight is most affected; length less so; head circumference is relatively spared ("brain-sparing effect")
- Results from an insult in later gestation (after 28 weeks) during the hypertrophic phase (cell enlargement and fat/muscle accretion)
- Due to redistribution of fetal blood to the brain, heart, and adrenals at the expense of the liver, adipose tissue, and abdominal organs
- Causes: Uteroplacental insufficiency (most common), pre-eclampsia, chronic maternal hypertension, renal disease, severe diabetes with vascular disease, multiple gestation
3. Intermediate / Combined IUGR (5-10% of cases)
- Occurs during the middle phase of fetal growth (20-28 weeks)
- Caused by conditions like chronic hypertension or lupus nephritis starting early in the second trimester
- Shows symmetric growth pattern but without significant brain-sparing
Medical Physiology, p. 1678-1679
Etiology / Causes
A. Fetal Causes
- Chromosomal abnormalities: Trisomy 13, 18, 21 (birth weights lowest in T13/T18)
- Congenital structural anomalies (22.3% of anomalous infants have IUGR)
- Congenital infections: TORCH (Rubella, CMV most established); Varicella, Toxoplasmosis, HIV, Malaria, Zika
- Metabolic disorders
B. Maternal Causes (most common category)
- Vascular disease: Pre-eclampsia, chronic hypertension
- Hypercoagulable states (acquired or inherited thrombophilia)
- Renal disease, Systemic Lupus Erythematosus
- Severe diabetes mellitus with vascular insufficiency
- Malnutrition (particularly third-trimester caloric restriction <1500 kcal/day)
- Teratogenic drugs: Phenytoin, warfarin, methotrexate, alcohol, narcotics
- Heavy smoking: Associated with small placentas and low birth weight
- High altitude (reduced oxygen availability)
- Multiple gestation
C. Placental Causes
- Placenta previa (low implantation)
- Placental abruption (retroplacental haematoma)
- Placental infarction
- Umbilical cord anomalies (single umbilical artery)
- Twin-twin transfusion syndrome (monochorionic twins)
- Histologic chorioamnionitis
Robbins Basic Pathology, p. 136-137; Creasy & Resnik MFM, p. 1037-1038
Pathophysiology
The fundamental pathway in most IUGR (especially asymmetric) is uteroplacental insufficiency leading to chronic fetal hypoxia and nutritional deprivation. In response:
- Fetal haemodynamic redistribution: Doppler studies show increased resistance in the umbilical artery and decreased resistance in the middle cerebral artery ("brain-sparing"). In severe cases, absent or reversed end-diastolic flow in the umbilical artery indicates critical compromise.
- Hormonal changes: Reduced IGF-1 (major intrauterine growth factor under nutritional control), reduced insulin levels; conversely, cortisol may be elevated.
- Metabolic adaptation: Decreased fat, glycogen, and protein deposition. The liver (a major glycogen store) is disproportionately small, explaining hypoglycaemia after birth.
- Haematopoietic response: Chronic hypoxia stimulates erythropoietin → polycythaemia.
Clinical Features / Recognition at Birth
Physical Appearance
- Low birth weight for gestational age
- Loose, dry, wrinkled skin with decreased subcutaneous fat (depleted fat stores)
- Thin, wasted limbs; prominent ribs
- Relatively large-appearing head (in asymmetric IUGR)
- Reduced abdominal circumference (small liver)
- Alert, wide-eyed appearance ("old man" facies)
- Meconium-stained skin, nails, and cord (chronic hypoxia causes meconium passage in utero)
Ponderal Index (PI)
- PI = Birth weight (g) × 100 / Crown-heel length (cm)³
- In asymmetric IUGR: PI is low (wasted)
- In symmetric IUGR: PI may be normal
Neonatal Complications
This is a high-yield list for exams:
| Complication | Mechanism |
|---|
| Perinatal asphyxia | Uteroplacental insufficiency; reduced reserve during labour |
| Meconium aspiration syndrome | In utero hypoxia → vagal stimulation → meconium passage |
| Hypoglycaemia | Depleted glycogen stores + hyperinsulinism (relative) |
| Hypothermia | Depleted subcutaneous fat; increased surface area:body mass ratio |
| Polycythaemia / hyperviscosity | Chronic hypoxia → ↑ erythropoietin → ↑ RBC production |
| Hypocalcaemia | Poor calcium stores, asphyxia-related |
| Necrotising enterocolitis (NEC) | Hypoxic redistribution away from gut; ischaemic injury |
| Persistent Pulmonary Hypertension (PPHN) | Chronic intrauterine hypoxia → pulmonary vascular remodelling |
| Pulmonary haemorrhage | Polycythaemia, PPHN |
| Thrombocytopenia | Bone marrow suppression from hypoxia |
| Immunodeficiency | Thymic atrophy, reduced lymphocyte function |
| Jaundice | Polycythaemia → increased bilirubin load |
Medical Physiology (Box 57-1, p. 1678)
Antenatal Diagnosis
Ultrasonography (key tool)
- Biometric parameters: Biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), femur length (FL) - plotted serially on growth charts
- AC is the most sensitive single parameter (reflects liver size and fat stores)
- HC/AC ratio: Elevated in asymmetric IUGR (head spared relative to abdomen)
- Estimated fetal weight (EFW) <10th percentile for gestational age
- Serial ultrasounds every 2-4 weeks to assess growth velocity
Doppler Studies
- Umbilical artery: Increased systolic/diastolic ratio, absent end-diastolic flow (AEDF), or reversed end-diastolic flow (REDF) - each indicates progressively worsening placental resistance
- Middle cerebral artery (MCA): Decreased resistance (compensatory vasodilation) - "brain sparing"
- Cerebroplacental ratio (CPR): MCA PI / UA PI - reduced CPR is an adverse sign
- Ductus venosus / umbilical venous pulsations: Absent or reversed 'a' wave in DV indicates imminent cardiac decompensation
Biophysical Profile (BPP)
- Assesses fetal breathing movements, body movements, tone, amniotic fluid volume, NST
- Score ≤4/10 is an indication for delivery
Other Investigations
- Chromosomal analysis (karyotype ± microarray) when structural anomaly or early-onset severe IUGR
- TORCH serology (maternal and sometimes fetal blood)
- Maternal blood pressure, urine protein, renal function, antiphospholipid antibodies, CBC
Management
Antenatal
- Identify and treat underlying cause (control hypertension, manage diabetes, stop smoking/alcohol)
- Serial fetal surveillance: Growth ultrasound every 2-4 weeks; Doppler weekly or more frequently if abnormal
- Corticosteroids (Betamethasone 12 mg IM × 2 doses 24h apart): if delivery anticipated before 34 weeks - accelerates lung maturity
- Aspirin (low-dose, 150 mg nocte) started before 16 weeks - reduces placental dysfunction in high-risk women
- Timing of delivery: Balance fetal compromise against prematurity:
- Absent/reversed end-diastolic flow: consider delivery at 34 weeks
- Abnormal ductus venosus: deliver regardless of gestation
- Continuous CTG abnormality: emergency delivery
Neonatal Management (Paediatrics focus)
At delivery:
- Anticipate birth asphyxia; have full resuscitation team available
- Clamp cord early only if baby compromised (delayed cord clamping preferred otherwise)
Immediate postnatal care:
- Prevent hypothermia: Warm environment, pre-warmed towels, incubator for preterm IUGR babies
- Blood glucose monitoring: Start within 30 minutes of birth; feed early (within 1 hour)
- Target glucose >2.6 mmol/L (>47 mg/dL); IV dextrose if hypoglycaemia persists
- Manage polycythaemia: If symptomatic (plethora, respiratory distress, jitteriness, convulsions) with haematocrit >65%: partial exchange transfusion with normal saline
- Calcium supplementation if hypocalcaemic
- Watch for NEC: Avoid aggressive enteral feeds in asphyxiated IUGR neonates; start minimal enteral nutrition and build up slowly
- Respiratory support: If meconium aspiration or PPHN - oxygen, CPAP, mechanical ventilation, inhaled NO for PPHN
Long-term Consequences
IUGR has significant long-term effects that extend well into adulthood:
- Neurodevelopmental: Cerebral dysfunction, learning disabilities, attention deficit, sensory impairment (visual and hearing), lower IQ - particularly in symmetric IUGR
- Growth: Approximately 10-15% of IUGR children fail to show "catch-up growth" and remain short; growth hormone therapy may be indicated in SGA children with persistent short stature after age 4 years
- Barker Hypothesis / Developmental Origins of Health and Disease (DOHaD): Fetal undernutrition programs permanent metabolic changes:
- Type 2 diabetes mellitus
- Insulin resistance / metabolic syndrome
- Hypertension
- Cardiovascular disease (coronary artery disease)
- Chronic kidney disease (reduced nephron number from impaired nephrogenesis)
- Reproductive: Girls who were IUGR have increased risks in their own pregnancies
Robbins Basic Pathology, p. 137; Brenner & Rector's The Kidney, p. 1723
Summary Table: Symmetric vs Asymmetric IUGR
| Feature | Symmetric IUGR | Asymmetric IUGR |
|---|
| Proportion | 20-30% | 70-80% |
| Timing of insult | Early (4-20 wk) | Late (after 28 wk) |
| Growth phase | Hyperplastic | Hypertrophic |
| Pathology | Fewer cells | Smaller cells, depleted glycogen/fat |
| Head circumference | Reduced | Relatively spared (brain-sparing) |
| HC/AC ratio | Normal | Elevated |
| Ponderal Index | Normal | Reduced (wasted) |
| Brain-sparing | Absent | Present |
| Common causes | TORCH, chromosomal, drugs | Uteroplacental insufficiency, PIH |
| Prognosis | Worse (fewer neurons) | Better if caught early |
Important Exam Points (High-Yield)
- IUGR definition: birth weight <10th percentile for gestational age
- Most common type: Asymmetric (70-80%), due to uteroplacental insufficiency
- Most common neonatal complication: Hypoglycaemia (depleted glycogen stores)
- Brain-sparing = relatively preserved head circumference in asymmetric IUGR
- "TORCH" infections = symmetric IUGR
- Absent/reversed umbilical artery end-diastolic flow = severe fetal compromise
- Long-term: Barker hypothesis - increased risk of adult-onset T2DM, hypertension, CAD
- IUGR children not showing catch-up by age 4 → consider recombinant GH therapy
Sources: Medical Physiology (Boron & Boulpaep), p. 1678-1679 | Robbins & Kumar Basic Pathology, p. 136-137 | Creasy & Resnik's Maternal-Fetal Medicine, p. 1037-1038